Episode
The State of Clinical Trial Outsourcing in the UK: Optimizing Site Selection, Resources, and Performance
- Published
- Apr 28, 2026
- Duration seconds
- 2606
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-cog-review-building-better-clinical-studies-7614513/episodes/the-state-of-clinical-trial-outsourcing-in-the-uk-optimizing-site-selection-resources-and-performance/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-cog-review-building-better-clinical-studies-7614513/the-state-of-clinical-trial-outsourcing-in-the-uk-optimizing-site-selection-resources-and-performance.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Hear leading UK clinical operations experts tackle today’s most critical challenges in clinical trial outsourcing, CRO selection, and site optimization—insight essential for any trial leader planning or delivering studies across the UK and global markets. Speakers Moderator: Sverre Bengtsson Fiona Shields, Head of UK Clinical Operations, Novartis Divya Chadha Manek, Director of Clinical Operations, EyeBio Suki Balendra , Director of Strategic Partnerships, Paddington Life Sciences Lucy Clossick Thomson , Head of Clinical Operations, Purespring Therapeutics Sarah Dealey, Director of Country & Site Operations, Biogen Janette Rawlinson , Patient Advocate and Research Partner, Various national/international patient organizations Episode Overview This episode features a candid panel discussion recorded live at COG UK. Senior clinical operations leaders from industry, biotech, NHS, and patient advocacy discuss the evolving landscape of clinical research in the UK, with direct implications for clinical trial outsourcing, CRO selection, and study delivery optimization. The panel explores why, despite a growing number of clinical trials, recruitment rates are falling and UK sites are receiving lower enrollment allocations. Experts dissect how conservative site targets, performance metrics, and resource constraints are impacting site selection decisions and sponsor strategies - a topic critical for clinical operations, outsourcing, and vendor management professionals handling global studies. Key areas include how to build more resilient and accountable sponsor–site partnerships, approaches to decentralizing trial delivery, tailoring CRO selection and outsourcing models to increase reliability, and deploying operational best practices that enable faster site activation, impro…